Date: Wednesday, April 18, 2018
Time: 1:00pm EST/ 10:00AM PST
The push for value-based care has fueled a rise in value assessment activity in the US that could resemble the environment across the rest of the world. With the recent stated goal of ICER to evaluate all new treatments and growing awareness of these by payers, syncing evidence strategy with pricing and market access activities will become a critical element to value demonstration and commercial success. Ross and Larry will share methods to enhance the use of clinical, economic and humanistic evidence to inform external value assessment activities as well as improve transparency and believability by reimbursement decision-makers to optimize market access.
After 45 minutes at this webinar you’ll:
• Understand how to prepare for an assessment by ICER and other third parties
• Recognize how assessing evidence gaps and subsequent evidence generation can inform value assessments
• Understand response techniques once an ICER review is underway
Speakers
Larry Blandford, PharmD, Executive Vice President and Managing Partner, Precision Xtract
Ross Maclean, MD, PhD, Senior Vice President, Head of Medical Affairs, Precision Xtract
Sponsored by:
